Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulla Feldt-Rasmussen

Showing results (221-230 of 342) with videos related to

Pageof 35
Sort By:
Frontiers in Endocrinology|October 17, 2022
Implementation of thyroid-related patient-reported outcomes in routine clinical practicePer Karkov Cramon, Jakob Bue Bjorner, Mogens Groenvold, et al.
Thyroid : Official Journal of the American Thyroid Association|July 3, 2016
Quality-of-Life Impairments Persist Six Months After Treatment of Graves' Hyperthyroidism and Toxic Nodular Goiter: A Prospective Cohort StudyPer Cramon, Kristian Hillert Winther, Torquil Watt, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 10, 2011
Similar clinical features among patients with severe adult growth hormone deficiency diagnosed with insulin tolerance test or arginine or glucagon stimulation testsAndrew Toogood, Georg Brabant, Dominique Maiter, et al.
European Journal of Endocrinology|February 19, 2013
Response to GH treatment in adult GH deficiency is predicted by gender, age, and IGF1 SDS but not by stimulated GH-peakUlla Feldt-Rasmussen, Georg Brabant, Dominique Maiter, et al.
Clinical Endocrinology|December 11, 2020
Sex differences in acromegaly at diagnosis: A nationwide cohort study and meta-analysis of the literatureJakob Dal, Benedikte G Skov, Marianne Andersen, et al.
Molecular Genetics and Metabolism|June 7, 2011
Diagnostic dilemma: a young woman with Fabry disease symptoms, no family history, and a "sequencing cryptic" α-galactosidase a large deletionUlla Feldt-Rasmussen, Robert Dobrovolny, Irina Nazarenko, et al.
European Journal of Heart Failure|May 26, 2010
Fabry disease mimicking hypertrophic cardiomyopathy: genetic screening needed for establishing the diagnosis in womenOle Havndrup, Michael Christiansen, Birgitte Stoevring, et al.
Clinical Endocrinology|April 27, 2022
Sex difference in patients with controlled acromegaly-A multicentre surveyJakob Dal, Christian Rosendal, Jesper Karmisholt, et al.
Trials|August 13, 2009
Rationale and design of the participant, investigator, observer, and data-analyst-blinded randomized AGENDA trial on associations between gene-polymorphisms, endophenotypes for depression and antidepressive intervention: the effect of escitalopram versus placebo on the combined dexamethasone-corticotrophine releasing hormone test and other potential endophenotypes in healthy first-degree relatives of persons with depressionUlla Knorr, Maj Vinberg, Marianne Klose, et al.
Plos One|December 7, 2019
Significant hearing loss in Fabry disease: Study of the Danish nationwide cohort prior to treatmentPuriya Daniel Yazdanfard, Christoffer Valdorff Madsen, Lars Holme Nielsen, et al.
Pageof 35

Showing results (221-230 of 342) with videos related to

Sort By:
Pageof 35
Frontiers in Endocrinology|October 17, 2022
Implementation of thyroid-related patient-reported outcomes in routine clinical practicePer Karkov Cramon, Jakob Bue Bjorner, Mogens Groenvold, et al.
Thyroid : Official Journal of the American Thyroid Association|July 3, 2016
Quality-of-Life Impairments Persist Six Months After Treatment of Graves' Hyperthyroidism and Toxic Nodular Goiter: A Prospective Cohort StudyPer Cramon, Kristian Hillert Winther, Torquil Watt, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 10, 2011
Similar clinical features among patients with severe adult growth hormone deficiency diagnosed with insulin tolerance test or arginine or glucagon stimulation testsAndrew Toogood, Georg Brabant, Dominique Maiter, et al.
European Journal of Endocrinology|February 19, 2013
Response to GH treatment in adult GH deficiency is predicted by gender, age, and IGF1 SDS but not by stimulated GH-peakUlla Feldt-Rasmussen, Georg Brabant, Dominique Maiter, et al.
Clinical Endocrinology|December 11, 2020
Sex differences in acromegaly at diagnosis: A nationwide cohort study and meta-analysis of the literatureJakob Dal, Benedikte G Skov, Marianne Andersen, et al.
Molecular Genetics and Metabolism|June 7, 2011
Diagnostic dilemma: a young woman with Fabry disease symptoms, no family history, and a "sequencing cryptic" α-galactosidase a large deletionUlla Feldt-Rasmussen, Robert Dobrovolny, Irina Nazarenko, et al.
European Journal of Heart Failure|May 26, 2010
Fabry disease mimicking hypertrophic cardiomyopathy: genetic screening needed for establishing the diagnosis in womenOle Havndrup, Michael Christiansen, Birgitte Stoevring, et al.
Clinical Endocrinology|April 27, 2022
Sex difference in patients with controlled acromegaly-A multicentre surveyJakob Dal, Christian Rosendal, Jesper Karmisholt, et al.
Trials|August 13, 2009
Rationale and design of the participant, investigator, observer, and data-analyst-blinded randomized AGENDA trial on associations between gene-polymorphisms, endophenotypes for depression and antidepressive intervention: the effect of escitalopram versus placebo on the combined dexamethasone-corticotrophine releasing hormone test and other potential endophenotypes in healthy first-degree relatives of persons with depressionUlla Knorr, Maj Vinberg, Marianne Klose, et al.
Plos One|December 7, 2019
Significant hearing loss in Fabry disease: Study of the Danish nationwide cohort prior to treatmentPuriya Daniel Yazdanfard, Christoffer Valdorff Madsen, Lars Holme Nielsen, et al.
Pageof 35